Answered You can hire a professional tutor to get the answer.
I will pay for the following essay Biological system. The essay is to be 3 pages with three to five sources, with in-text citations and a reference page.Another category of devices, know as, Ventricul
I will pay for the following essay Biological system. The essay is to be 3 pages with three to five sources, with in-text citations and a reference page.
Another category of devices, know as, Ventricular assist devices (VADs) use model-based control to make required adjustment for changes in patient needs. This reflects on the fact that these devices are related to automation and control.
The article reflect on the health care or medicine industry. Different controls and sensors have been used for each device. For the artificial pancreas linear and nonlinear proportional-derivative (PD) algorithms to emulate the naturalistic biphasic insulin secretion profile. Advanced control technologies have been, including variations on PID control, run-to-run control and model predictive control.
Control and manipulated variables differ from device to device as all devices are used for different reasons and are also based on different models. The articles highlights the issue of ventricular assist devices. Although high-level physiologic control is a promising technology a thorough research is required to understand how to control the speed of the pump and in response to what sensors.
The paper reflects on the gap between engineers and clinicians. It shows that engineer can contribute and are highly contributing to the health care industry. With the help of automation and control, many traditional issues have been overcome and have caused an advancement in the field of biotechnology. Areas under research have given a glimpse of hope for many hopeless individuals and families suffering from different disease. Even though so much advance has and is taking place, they are many barriers that are causing resistance to the advancement. Not only are these barriers to be overcome but also different ways of improvement are to be sought. Those which are known should also be implemented.
From a regulatory point of view, during development the centre of focus shouldn’t be the drug but the device. This is because opting to focus on the device usually leads to a shorter pathway of
